Literature DB >> 202716

Carcinogenic effect of N-nitroso-2,6-dimethylmorpholine in Syrian golden hamsters.

G Reznik, U Mohr, W Lijinsky.   

Abstract

N-Nitroso-2,6-dimethylmorpholine was intragastrically administered to Syrian golden hamsters at four different dose levels [74 mg/kg body wt = 1/5 median lethal dose (LD50); 37 mg/kg body wt = 1/10 LD50; 18 mg/kg body wt = 1/20 LD50; and 9 mg/kg body wt = 1/40 LD50]. Up to a 71% rate of pancreatic tumors was induced. These tumors were adenomas or adenocarcinomas of ductal origin. In addition, neoplasms developed in different percentages in the nasal cavities, larynx, trachea, lungs, liver, gallbladder, kidneys, and forestomach. The number of tumors induced was not significantly dose-dependent.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 202716     DOI: 10.1093/jnci/60.2.371

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

Review 1.  Structure-activity relations in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Carcinogenesis by oxygenated nitrosomethylpropylamines in Syrian hamsters.

Authors:  W Lijinsky; R M Kovatch; G L Knutsen
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

3.  Comparative study on the carcinogenicity of N-nitroso-2,6-dimethylmorpholine in the European hamster.

Authors:  J Althoff; U Mohr; W Lijinsky
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

Review 4.  Animal models of exocrine pancreatic carcinogenesis.

Authors:  M S Rao
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  A carcinogenic potency database of the standardized results of animal bioassays.

Authors:  L S Gold; C B Sawyer; R Magaw; G M Backman; M de Veciana; R Levinson; N K Hooper; W R Havender; L Bernstein; R Peto
Journal:  Environ Health Perspect       Date:  1984-12       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.